HALOPERIDOL AND REDUCED-HALOPERIDOL CONCENTRATIONS IN PLASMA FROM CHRONIC-SCHIZOPHRENIC PATIENTS

被引：3
|
作者：
AYMARD, N
LEYRIS, A
TOFFIS, V
VIALA, A
EPINETTE, C
DELTEIL, P
机构：
[1] UNIV PARIS 05,PHARMACOL LAB,F-75270 PARIS 06,FRANCE
[2] CHS ST ANNE,UNITE PHARMACOL,F-75014 PARIS,FRANCE
[3] CHS ST ANNE,SERV SANTE MENTALE,UNITE GEORGES CABANIS,F-75014 PARIS,FRANCE
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1990年 / 183卷 / 06期
关键词：
D O I：
10.1016/0014-2999(90)93854-J
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2301 / 2302
页数：2
相关论文
共 50 条
  • [31] Plasma alpha-one acid glycoprotein and haloperidol concentrations in schizophrenic patients
    Jann, MW
    Crabtree, BL
    Pitts, WM
    Lam, YWF
    Carter, JG
    NEUROPSYCHOBIOLOGY, 1997, 36 (01) : 32 - 36
  • [32] KETONE REDUCTASE-ACTIVITY AND REDUCED HALOPERIDOL HALOPERIDOL RATIOS IN HALOPERIDOL-TREATED SCHIZOPHRENIC-PATIENTS
    HUANG, HF
    JANN, MW
    TSENG, YT
    CHUNG, MC
    CHIEN, CP
    CHANG, WH
    PSYCHIATRY RESEARCH, 1995, 57 (02) : 101 - 108
  • [33] HALOPERIDOL DECANOATE V FLUPHENAZINE DECANOATE AS MAINTENANCE THERAPY IN CHRONIC-SCHIZOPHRENIC INPATIENTS
    MCKANE, JP
    ROBINSON, ADT
    WILES, DH
    MCCREADIE, RG
    STIRLING, GS
    BRITISH JOURNAL OF PSYCHIATRY, 1987, 151 : 333 - 336
  • [34] QUANTIFICATION OF HALOPERIDOL AND REDUCED HALOPERIDOL METABOLITE IN PLASMA OF PSYCHIATRIC-PATIENTS
    BROWNING, JL
    HARRINGTON, CA
    BURCH, NR
    DAVIS, CM
    FEDERATION PROCEEDINGS, 1982, 41 (05) : 1635 - 1635
  • [35] CIS(Z)-CLOPENTHIXOL AND HALOPERIDOL IN CHRONIC-SCHIZOPHRENIC PATIENTS - A DOUBLE-BLIND CLINICAL MULTICENTER INVESTIGATION
    HEIKKILA, L
    LAITINEN, J
    VARTIAINEN, H
    ACTA PSYCHIATRICA SCANDINAVICA, 1981, : 30 - 38
  • [36] CYPROHEPTADINE AUGMENTATION OF HALOPERIDOL IN CHRONIC-SCHIZOPHRENIC PATIENTS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    LEE, HS
    SONG, DH
    KIM, JH
    LEE, YM
    HAN, ES
    YOO, KJ
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 (02) : 67 - 72
  • [37] HALOPERIDOL REDUCTASE-ACTIVITY IN THE RED-BLOOD-CELLS OF CHRONIC-SCHIZOPHRENIC PATIENTS AND NORMAL SUBJECTS
    CHAN, MY
    WONG, BYM
    YAU, KW
    TAM, WYK
    ASIA PACIFIC JOURNAL OF PHARMACOLOGY, 1992, 7 (01): : 57 - 60
  • [38] CYPROHEPTADINE AUGMENTATION OF HALOPERIDOL IN THE CHRONIC-SCHIZOPHRENIC PATIENTS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    SHICK, LH
    HAK, KJ
    MOON, LY
    SUN, HE
    KWON, KM
    HOON, OB
    KIL, MS
    JOON, YK
    YOUNG, LH
    NEUROPSYCHOPHARMACOLOGY, 1993, 9 (02) : S55 - S55
  • [39] PHARMACOKINETICS OF HALOPERIDOL AND HALOPERIDOL DECANOATE IN SCHIZOPHRENIC-PATIENTS
    NAYAK, RK
    NAIR, NPV
    DOOSE, DR
    MCCARTHY, LR
    DESIRAJU, RK
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (02) : 217 - 217
  • [40] Evolution of plasma homovanillic acid (HVA) in chronic schizophrenic patients treated with haloperidol
    Galinowski, A
    Poirier, MF
    Aymard, N
    Leyris, A
    Beauverie, P
    Bourdel, MC
    Loo, H
    ACTA PSYCHIATRICA SCANDINAVICA, 1998, 97 (06) : 458 - 466
12345